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ABSTRACT 
 
Phytoestrogens are a class of compounds that have estrogen-like functions or structure. This 
research was conducted to find out the phytoestrogens activity in Chrysophyllum cainito leaves, in 
increasing the vertebrae trabecular bone density of female mice, using dexamethasone induction as 
osteoporosis model.  The 70% ethanol extract of C. cainito leaves was given to female mice with dose of 100; 
200; and 400 mg/kgBW mice/day after being induced orally with dexamethasone with 0.145 mg/kgBW 
mice/day. The positive control used was 1.3 mg/kgBW mice/day alendronate. This research had been done 
in four weeks. The increasing of trabecular vertebrae bone density of female mice was measured with 
Histomorphometry staining methods. The result showed the 70% ethanol extract of C. cainito leaves have 
activity in increasing trabecular vertebrae bone density for female mice with optimum dose of 400 
mg/kgBW mice/day. This activity occurs because phytoestrogens content in 70% ethanol extract of C. 
cainito leaves, that may replace the function of estrogen in its bond with ER. 
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INTRODUCTION  
Osteoporosis is a condition of bone mass 
degradation along with microarchitecture damage 
which causes improvement of bone fracture risk 
(Ahmed and Elmantaser, 2009; Agrawal and Gupta, 
2013). The microarchitecture damage in bone 
tissue is related tightly to the existence of turnover 
abnormality in the bone remodeling process, that 
creates unbalanced of bone formation and 
resorption process (Kini and Nandeesh, 2012; Lee 
et al., 2013; Meeta, 2013). Estrogen deficiency is 
known as one of important factor that creates bone 
remodeling unbalance process for 
postmenopausal woman (Lee et al., 2013; Dipiro et 
al., 2008), and hormone replacement therapy 
(HRT) is a medical treatment which mostly 
recommended for osteoporosis in postmenopausal 
woman (Rachman et al., 2004). Unfortunately, 
giving HRT in long-term therapy can create a 
potential side effect such as coronary event, venous 
thromboembolism, stroke, breast cancer, and 
dementia (Constantine and Pickar, 2005; Wibowo, 
2009; Lee et al., 2013).  
Phytoestrogens are a class of compounds  
from   the  plant  that   can  substitute   the   estrogen 
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function in its bound with estrogen receptor. 
Instead of easily found in plants and does not have  
the side effect, the phytoestrogens group were also 
reported to have benefits to increase the bone 
mass (Urasopon et al., 2008; Villiers, 2009; Yang et 
al., 2012). Then, it becomes the potential 
alternative medical treatment for postmenopausal 
woman (Yang et al., 2012). Chrysophyllum cainito 
was known as plant which contains 
phytoestrogens. C. cainito grow a lot in East Java, 
Indonesia. People use its fruit to be consumed as 
food. However, this plant has not been widely 
studied. One of the studies showed the 70% 
ethanol extract of C. cainito leaves contained 
polyphenol, flavonoid, isoflavone, tannin, sterol, 
and triterpenoid compound group  (Luo et al., 
2002; Koffi et al., 2009). Isoflavone, sterol, and 
triterpenoid are compound which has an 
estrogenic activity that is included in the 
phytoestrogens compound.  
To know the phytoestrogens activity of C. 
cainito leaves in fixing bone remodeling process, 
the mice (Mus musculus) trabecular vertebrae bone 
density level measurement was done by giving the 
treatment of 70% ethanol extract of C. cainito 
leaves, then the measurement of mice bone density 
level was done by histomorphometry and HE 
methods.   
 
 
Activity of 70% Ethanol Extract 
120  Traditional Medicine Journal, 23(3), 2018 
METHODOLOGY 
Materials 
Plant Material 
C. cainito was taken and identified in UPT 
Materia Medica, Batu, Indonesia in July 2017 with 
specimen number 1b-2b-3b-4b-6b-7b-9b-10b-
11b-12b-13b-14a-15a-109b-119b-120a-121b-
124b-125a-126b-127a. The fresh leaves were 
dried and grinded to produce green leaves powder.  
 
Chemical 
The 70% ethanol (Merck), dexamethasone 
(Kimia Farma), alendronate (Novel), CMC Na 0.5% 
and chloroform (Merck) were purchased from 
Phytochemistry Laboratory in Pharmacy 
Department, Faculty of Medical and Health Science, 
Maulana Malik Ibrahim State Islamic University, 
Malang. The 10% formalin, 10% formic acid, 70% 
alcohol, 3% nitrate acid, acetone, 1.5% xylol, liquid 
paraffin, glycerin, ammonia solution, hematoxylin 
and eosin dye were acquired from Histology 
Laboratory, Faculty of Medicine, Universitas 
Airlangga, Surabaya. 
 
Methods 
Sample Preparation 
C. cainito leaves were extracted with 70% 
ethanol with ultrasonic assisted extraction 
methods, and were prepared to produce extract 
suspension in aquadest with dose 100; 200; and 
400 mg/kgBW mice/day. Dosage one was made by 
mixing 280 mg extracts to 50 ml CMC Na 0.5%. 
Dosage two was made by mixing 560 mg extract to 
50 ml CMC Na 0.5%. Dosage three was made by 
mixing 1120 mg extract to 50 ml CMC Na 0.5%. 
 
Treatment 
Female mice were induced with 
dexamethasone of 0.145 mg/kgBW mice/day 
orally. Then each group was treated with 100; 200; 
and 400 mg/kgBW mice/day samples, and 1.3 
mg/kgBW mice/day alendronate as positif control. 
It had been given in four weeks orally for five 
groups (contains six mice in each group). The next 
step was mice surgery to take the trabecular 
vertebrae bone. The vertebrae bone was cut in 
thorax part and put inside the bottle with 10% 
formalin. Trabecular vertebrae bone then inserted 
in decalcification solution (7.0g aluminum 
chloride, 8.5 g chloride acid, and 5.0 ml formic acid 
in 100 ml water) and then the density were tested. 
Neutralization was done using sodium sulfate 2% 
for 24 hours. Trabecular vertebrae bone then 
washed using water for 12 hours and rinsed with 
70% alcohol. The bone then blocked with paraffin 
and cut with microtome. Next step was hydration 
with 70% alcohol and hematoxylin as the main dye. 
The bone was inserted in 1% acid alcohol and 
ammonia solution, and was added with 1% eosin. 
The final step was clearing the bone with 1.5% 
xylol, and plated on object glass. The observation 
slide was analyzed using an Olympus Cellsens 
program with 100x zoom. 
 
Data Analysis 
The research result was analyzed using one-
way ANOVA with a significance value of 0.05 (p ≤ 
0.05). If there was any difference then would be 
tested by using post hoc testing with LSD to test the 
difference and average of the treatment. 
 
RESULTS AND DISCUSSION 
 Extraction of C. cainito leaves with 70% 
ethanol produces extracts with yield value of 
13.92%. Osteoporosis was created with 
dexamethasone induction of 0.145 mg/kgBW 
mice/day orally for female mice. Mice with 
osteoporosis could be distinguished from healthy 
mice by looking at their crooked back (kyphotic) 
(Figure 1). 
            
(a)                        (b) 
 
Figure 1. Normal mice. (a) and mice with osteoporosis; (b) The change of vertebrae posture becomes 
kyphotic is shown by arrows. 
 
Burhan Ma’arif 
Traditional Medicine Journal, 23(3), 2018  121 
Dexamethasone is one of the synthetic 
corticosteroids. By treatment this medicine for 
four weeks for mice, is equal to 3-4 years treatment 
for humans (Brunton et al., 2005; Noor, 2014). The 
use of corticosteroid group compounds for a long-
term period (3-6 months, or more) can cause the 
inhibition of bone formation process (Kemenkes 
RI, 2015). The use of glucocorticoid for long term 
also can reduce the level of estrogen and 
progesterone hormone, while the deficiency of 
estrogen is considered as one factor that causes the 
imbalance of bone remodeling process and has a 
role in increasing bone resorption process (Dipiro 
et al., 2008). Figure 2 shows the average result of 
trabecular vertebrae bone density for each group, 
whereas (Table I) shows percentage of bone 
density improvement of trabecular vertebrae 
compared to negative control. 
Homogenity test of mice’s bone density with 
p > 0.05 showed that average data of bone density 
in the experimental group had a similar variant 
(homogenous). Normality test of average data of 
mice’s bone density in each group with p > 0.05, 
showed that the data was normally distributed. 
Therefore, it fulfilled the parametric statistics test 
qualification of one-way ANOVA.  
In one-way ANOVA statistical test, the 
significance level was p < 0.05. It showed that there 
was a minimal difference between a pair of the 
experimental group. To know the significant 
difference of experimental group, post hoc test was 
done using the LSD method. The LSD test result 
showed the significant difference between the 
bone density value of the treatment group with the 
dosage of 200 and 400 mg/kgBW mice/day 
compare to the negative negatif control group with 
p-value 0.011 and 0.001. It showed that 70% 
ethanol extract of C. cainito leaves in that dosage 
could increase bone density. While for the extract 
with dosage of 100 mg/kgKg mice/day with p-
value = 0.277 could not increase the bone density, 
because there was no significant difference with 
the negative control group. LSD test result showed 
the significant difference between two treatment 
groups 100 mg/kgBW mice/day and 200 
mg/kgBW mice/day mice/day with alendronate 
group with p value each is 0.000 and 0.007. 
Meanwhile, for extract with the dose of 400 
mg/kgBW mice/day showed that 70% ethanol 
extract of C. cainito leaves on that dosage did not 
have significant difference compare to alendronate 
group with p value 0.139.
 
 
 
Figure 2. Bone density values of each group. 
 
Table I. Bone Improvement Percentage 
 
Groups Bone Improvement Percentage 
C. cainito etanol extract dose 100 mg/kgBW mice/day 14.92 % 
C. cainito etanol extract dose 200 mg/kgBW mice/day 66.22 % 
C. cainito etanol extract dose 400 mg/kgBW mice/day 118.66 % 
Positive Control (Alendronate 1.3 mg/kgBW mice/day) 147.93 % 
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The result showed the tendency of 
improvement of trabecular vertebrae bone density 
value by giving 70% ethanol extract of C. cainito 
leaves. According to LSD test result, it was found 
that 70% ethanol extract of C. cainito leaves with 
dosage of 100 mg/kgBW mice/day did not have 
pharmacology effect. Dosage of 200 mg/kgBW 
mice/day could give pharmacology effect by 
increasing bone density, and for the dosage of 400 
mg/kgBW mice/day had activity level that was 
almost equal with alendronate in increasing bone 
density.  
The histopathology check was done and 
showed in Figure 3. The cancellous bone (x) and 
solid bone (y) were shown in different colors. 
There were alpha and beta estrogen receptor (ERα 
and ERβ) expressions in bone, which had a role in 
maintaining homeostasis of bone density. In the 
situation of estrogen deficiency, which was caused 
by dexamethasone induction, there was no 
estrogen binding with ER. Therefore, it caused pro-
osteoclastogenesis cytokines such as Tumor 
Necrosis Factor-Alpha (TNF-α), Interleukin-1 (IL-
1) and Interleukin-6 (IL-6) produced in high 
number. The production of this cytokines would 
induce preosteoclast differentiation to mature 
osteoclast, and would occur massive bone 
resorption   process.   Moreover,   the   increase   of  
cytokines also would inhibit preosteoblast 
differentiation to mature osteoblast, which then 
headed to the inhibition of bone formation process. 
Insulin-like Growth Factor-1 (IGF-1) and 
Insulin-like Growth Factor-2 (IGF-2) in high 
number. The decreasing of growth factor could 
increase osteoclastogenesis and inhibit 
osteoblastogenesis, so that the osteoporosis 
tended to occur (Kawiyana, 2009; Kini and 
Nandeesh, 2012; Meeta, 2013).  
In this research, the increasing of trabecular 
vertebrae bone density for female mice could occur 
because of phytoestrogens content in 70% ethanol 
extract of C. cainito leaves. The phytoestrogens 
compound were bind to ER in cell nucleus and 
reserved the situation that happened in estrogen 
deficiency (Yang et al., 2012). Phytoestrogen 
binding with ER caused the decreasing of 
osteoclastogenesis and bone resorption, as well as 
the increasing of osteoblastogenesis and bone 
formation (Laswati et al., 2015). 
 
CONCLUSION 
The 70% ethanol extract of C. cainito leaves 
have activity in increasing trabecular vertebrae 
bone density for female mice with optimum dose of 
400 mg/kgBW mice/day. This activity can occur 
because phytoestrogens content in 70% ethanol 
   
(a) (b)          (c) 
 
   
(d)   (e) 
 
Figure 3. Histopathology of female mice’s vertebrae trabecular bone; (a) Extract of C. cainito leaves 100 
mg; (b) Extract of C. cainito leaves 200 mg; (c) Extract of C. cainito leaves 400 mg; (d) Alendronate; and 
(e) Negative Control  
 
Burhan Ma’arif 
Traditional Medicine Journal, 23(3), 2018  123 
extract of C. cainito leaves, that can replace the 
function of estrogen in its bond with ER. 
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